Join
Live feed
·
INSIDERFilingvia Quantisnow
Syndax Pharmaceuticals Inc. logo

Director Rizo Aleksandra was granted 25,000 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
SNDX· Syndax Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SNDX (Syndax Pharmaceuticals Inc.) and more on Quantisnow.

Director Rizo Aleksandra was granted 25,000 shares (SEC Form 4) | Quantisnow